Thailand’s Government Pharmaceutical Organisation (GPO) launched the third phase of human trials of its COVID HXP-GPOVac on 4,000 volunteers today (Friday), after the success of the second phase involving 300…
Read More
Thailand’s Government Pharmaceutical Organisation (GPO) launched the third phase of human trials of its COVID HXP-GPOVac on 4,000 volunteers today (Friday), after the success of the second phase involving 300…
Read More
The first phase of human trials of Thailand’s vaccine candidate, jointly developed domestically by the Government Pharmaceutical Organization (GPO) and the Tropical Medicine Faculty of Mahidol University, has produced a…
Read MorePage 1 of 1